Navigation Links
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer

Bayer HealthCare Pharmaceuticals Inc. (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that a Supplemental New Drug Application (sNDA) for Nexavar(R) (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer.

Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer. The companies also confirmed that they are planning a company- sponsored Phase 3 study of Nexavar in the adjuvant treatment of HCC following the complete removal of early stage liver cancer.

The sNDA submission is based on positive data from the international, Phase 3, placebo-controlled Sorafenib HCC Assessment Randomized Protocol (SHARP) trial which demonstrated that Nexavar extended overall survival by 44 percent in patients with HCC (HR=0.69; p=0.0006) versus placebo.

There were no significant differences in serious adverse event rates between the Nexavar and placebo-treated groups with the most commonly observed adverse events in patients receiving Nexavar being diarrhea and hand-foot skin reaction. Currently, there are no FDA-approved drug therapies that significantly extend survival of patients with liver cancer.

"These results are particularly meaningful considering that death rates from liver cancer continue to increase," said Susan Kelley, M.D., vice president, Therapeutic Area Oncology, Bayer HealthCare Pharmaceuticals. "After more than 100 clinical studies of many agents over three decades.

Nexavar is the first drug therapy to demonstrate a significant survival benefit for patients with HCC, and, if approved, may fulfill a serious unmet need with a manageable toxicity profile."

HCC, the most common form of liver cancer, is responsible for about 90 percent of the primary liver cancers in adults. It is the fifth
'"/>




Page: 1 2

Related medicine news :

1. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
2. Bayer Wins Positive Response For Marketing Its Cancer Drug
3. Genomatix Licensed By Bayer Healthcare
4. Bayer to Market Biocon Insulin in China
5. Test for Esophageal Reflux Licensed to Bayer by University
6. Recd Number of Abstracts Submitted for Sci Cong on Osteoporosis
7. MBBS Aspirants Get 90 Days To Submit Caste Validity Certificate
8. New Drug Application Submitted for Investigational Antibiotic Doripenem
9. New Supplemental Therapy for Common Jaw Disorder
10. Prostate Cancer Can Be Treated By Application Of LASER Technology
11. Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human
Post Your Comments:
(Date:12/24/2014)... (PRWEB) December 24, 2014 Connie Casad, ... and functional medicine advocate with 30 years of practice ... to evaluate the health benefits of dietary detoxification. The ... new participants following excellent results from test patients who ... asked to explain her interest in conducting the study, ...
(Date:12/24/2014)... 24, 2014 Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... tort litigation currently underway in Pennsylvania’s Philadelphia Court of ... December 24, 2014, court documents indicate that 1,183 claims ... individuals who developed gynecomastia (male breast growth) and other ... Court indicates that this represents an increase of more ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Dr. Vu ... the expansion of his practice and med-spa with the ... practice’s growing list of cosmetic treatments and services. , ... into the skin,” says Dr. Ho. “As a result ... such as wrinkles, sun spots, discolorations or blemishes.” , ...
(Date:12/24/2014)... UWDress.com, the famous women’s dress supplier, has presented its new ... wedding gown promotion. , For those who prefer ... way, the collection should be a great choice. The dresses ... they are available with custom service. , Now, all the ... to 75% off; most of them come in hot designs. ...
(Date:12/24/2014)... 2014 The report “Stivarga (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... a drug which is used in the treatment of ... and is also prescribed to patients who suffer from ... approved is a multi-kinase inhibitor and it blocks many ...
Breaking Medicine News(10 mins):Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... Center for Research and Innovation (GCRI), in cooperation with the ... treatments and challenges of tuberculosis on Thursday, March 31, from ... the German House New York (871 United Nations Plaza, First ... with HIV/AIDS, is one of today,s deadliest threats. Killing one ...
... (HealthDay News) -- A poor diet is associated with a ... study has found. Researchers analyzed data from 72,833 older ... more than a single nutrient were associated with a 21 ... with deficiencies in three nutrients. Women with anemia consumed ...
... release is available in French . , ... written action plan for asthma treatment, attached to the ... visits for asthma often signal a management failure," said ... of Pediatrics and the Sainte-Justine University Hospital Centre. "This ...
... March 25, 2011) Ching-Hon Pui, M.D., a world renowned ... Hospital, is the recipient of the 2011 Joseph H. ... from the American Association for Cancer Research (AACR). ... Achievement in Clinical Research is presented to a scientist ...
... Team Science Award will be given to a ... and clinicians from Fred Hutchinson Cancer Research Center ... on human papillomavirus (HPV) for more than 20 ... research team for its innovative and meritorious science ...
... Network and the American Association for Cancer Research awarded ... their innovative research in the field of pancreatic cancer. ... represents the largest annual disbursement since the Pancreatic Cancer ... will be honored at a recognition event scheduled during ...
Cached Medicine News:Health News:Tuberculosis: A neglected pandemic 2Health News:Poor Eating Habits May Lead to Anemia in Older Women 2Health News:Young asthmatics are leaving emergency rooms missing critical documentation 2Health News:Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award 2Health News:Research team honored for innovative science to advance cancer research 2Health News:Research team honored for innovative science to advance cancer research 3Health News:Pancreatic Cancer Action Network and AACR award research grants totaling nearly $3 million 2Health News:Pancreatic Cancer Action Network and AACR award research grants totaling nearly $3 million 3
(Date:12/24/2014)...  Lockton Dunning Benefits, the Dallas ... addition of Vice President Kim Foerster ... Consulting team, Excelsior Solutions. Foerster ... the position.  Most recently, she worked as the ... Pharmacy, where she has held various managerial positions ...
(Date:12/24/2014)...  Medical Science Liaisons play a large role in ... medical device industry and key stakeholders, the role of ... as the device industry relies on them to build ... benchmarking firm, Best Practices, LLC, one area where Medical ... by harnessing new technology to enable education. Online conferences ...
(Date:12/22/2014)... --  TRU-D SmartUVC LLC, producers of the first ... that the General Services Administration has awarded the company ... This newly formed agreement will allow TRU-D SmartUVC ... including Department of Veteran Affairs and Department of Defense ... solutions for the Ebola effort in West ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Role of Medical Science Liaisons Evolving in Medical Device Sector 2TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... CoreLab Partners, Inc. has launched a new ... Medical Parameters for Solutions (A.M.P.S.) LLC. "We ... semi-automated CalECG v3 solution for the analysis of ECGs," ... Mike Woehler. "This new application represents our commitment to ...
... (ECIA:PK), a medical device company owning patented surgical technology that ... reported its financial results for its second fiscal quarter ended ... loss of $469,000 or $(0.07) per share for the second ... $2.830 million and net service revenue of $437 thousand. Total ...
Cached Medicine Technology:CoreLab Partners Now Offers Semi-automated ECG Solutions 2CoreLab Partners Now Offers Semi-automated ECG Solutions 3Encision Reports 14% Revenue Increase in Second Quarter Results 2Encision Reports 14% Revenue Increase in Second Quarter Results 3Encision Reports 14% Revenue Increase in Second Quarter Results 4
Sterile Single Loop Pediatric Suction Catheters with TOUCH-TROL Valve...
... design was created to be less ... providing high suctioning efficiency. Our infant ... 10 Fr) feature depth markings to ... complete catheter line is available in ...
Suction catheter with thumb valve, two eyes, whistle tip...
Tracheal Suction Latex Rubber Catheters - Thumb Control Valve...
Medicine Products: